ArticleCureus2025
Alice in Wonderland Syndrome in a Child Following Epstein-Barr Virus Infection: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alice in Wonderland syndrome (AIWS) is a rare and often underrecognized neuropsychiatric phenomenon characterized by transient episodes of visual and somatosensory perceptual distortions, including micropsia, macropsia, altered body image, derealization, and disrupted perception of time. It most commonly affects children and adolescents and can be triggered by various conditions, including migraine, epilepsy, medications, and infections. We present the case of a 10-year-old previously healthy girl who developed intermittent episodes of micropsia, time distortion, and depersonalization shortly after recovering from a self-limited febrile illness. Her history and symptoms were classic for AIWS, and serologic testing confirmed an acute Epstein-Barr virus (EBV) infection, with positive viral capsid antigen (VCA) IgM and IgG and negative EBNA-1 IgG, indicating a primary EBV infection. Extensive diagnostic workup, including basic metabolic panel, inflammatory markers, autoimmune screening, neuroimaging (MRI), and electroencephalography (EEG), revealed no abnormalities, effectively ruling out structural, epileptic, or metabolic causes. The patient retained full orientation and insight throughout the episodes, and her symptoms gradually resolved over the course of four weeks without pharmacologic intervention. Supportive care, patient and family reassurance, and close outpatient follow-up were sufficient for full recovery. This case reinforces the strong association between AIWS and post-infectious states, particularly EBV, and emphasizes the importance of early recognition and appropriate evaluation to avoid unnecessary interventions. Increased clinician awareness of AIWS is crucial in guiding timely diagnosis, alleviating anxiety, and ensuring optimal management in affected pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.